The Dark Side of Onglyza and Heart Failure
Those afflicted with Type 2 diabetes need medication to control their high blood sugar and end up turning to the dominate prescriptions on the market: Onglyza and Kombiglyze XR. Released in 2009, Onglyza quickly became a popular choice of medication to control blood sugar amongst Type 2 diabetics since it didn’t cause excess weight gain
Read More
Onglyza and the Risks of Heart Failure and Pancreatic Cancer
Where you or a loved one harmed by Onglyza? This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm Researchers associate this Type 2 diabetes drug with some very serious complications. These include heart failure, pancreatitis, and pancreatic cancer. The national pharmaceutical practice group of The Michael Brady Lynch Firm is
Read MoreThe Dangers of Heart Failure Associated with Onglyza
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. When Onglyza (saxagliptin) arrived on the marker in 2009, it was seen as a new frontier in maintaining blood sugar levels in type 2 diabetics. The excitement faded when the drug was linked to heart failure and other serious complications. These
Read More